Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas. (Q46955939)
Jump to navigation
Jump to search
scientific article published in November 1986
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas. |
scientific article published in November 1986 |
Statements
Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas (English)
Levin VA
Phuphanich S
Liu HC
Da Silva V
Murovic J
Choucair A
Chamberlain M
Berger M
Seager M
1 November 1986